Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

[Endothelial cells and coagulation abnormalities].

M Uchiba¹, K Okajima

¹Department of Laboratory Medicine, Kumamoto University School of Medicine.

Rinsho Byori. the Japanese Journal of Clinical Pathology

|May 16, 2000

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Colour differences in Caucasian and Oriental women's faces illuminated by white light-emitting diode sources.

International journal of cosmetic science·2018

Same author

A phase III clinical trial of a mixture agent of plasma-derived factor VIIa and factor X (MC710) in haemophilia patients with inhibitors.

Haemophilia : the official journal of the World Federation of Hemophilia·2016

Same author

FOXG1 mutations in Japanese patients with the congenital variant of Rett syndrome.

Clinical genetics·2011

Same author

Non-invasive measurement of local pulse pressure by pulse wave-based ultrasound manometry (PWUM).

Physiological measurement·2011

Same author

Administration of an angiotensin-converting enzyme inhibitor improves vascular function and urinary albumin excretion in low-risk essential hypertensive patients receiving anti-hypertensive treatment with calcium channel blockers. Organ-protecting effects independent of anti-hypertensive effect.

Clinical and experimental hypertension (New York, N.Y. : 1993)·2011

Same author

Mutations of the E1beta subunit gene (PDHB) in four families with pyruvate dehydrogenase deficiency.

Molecular genetics and metabolism·2008

Antithrombin and activated protein C protect endothelial cells from inflammatory damage by maintaining anticoagulant functions. These systems may treat sepsis-related coagulation disorders by inhibiting both clotting and inflammation.

Area of Science:

Biochemistry
Cell Biology
Immunology

Context:

Endothelial cells possess critical anticoagulant systems: heparan sulfate-antithrombin and thrombomodulin-protein C.
Inflammation, triggered by cytokines like tumor necrosis factor-alpha (TNF-α), impairs these endothelial anticoagulant functions.

Purpose:

To investigate the role of antithrombin and activated protein C in maintaining endothelial anticoagulant properties during inflammation.
To explore their potential therapeutic applications in inflammatory and coagulation disorders.

Summary:

Under inflammation, TNF-α downregulates endothelial heparan sulfate and thrombomodulin, reducing anticoagulant capacity.
Antithrombin and activated protein C counteract inflammatory effects, inhibiting coagulation and TNF-α production.

Related Experiment Videos

These agents may also regulate TNF-α-induced tissue factor expression on endothelial cells.

Impact:

Antithrombin and activated protein C show promise for treating coagulation abnormalities in sepsis and inflammation.
They offer a dual benefit by inhibiting coagulation and preserving endothelial anticoagulant functions.